2 ASX shares to buy and hold till 2030

2 top shares to buy and hold till 2030 – Telstra and CSL

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

So, you have some spare cash to spend on the sharemarket?

Maybe this is the first time you've bought some ASX shares. If so, congratulations! Or maybe you are looking to add to your current share portfolio.

Either way, here's 2 of Australia's largest companies that in my opinion both have a very bright future ahead and are worthy of a place in your portfolio.

Telstra Corporation Ltd (ASX: TLS)

Telstra is of course Australia's largest telco, and has held the number 1 position in Australia's telecommunications market for several decades now.

Although it has been undergoing some recent short-term pain as it restructures into a leaner company, I believe that this will position it well to remain in a dominant position and more effectively compete with the growing competition in the fixed broadband market, as Australia's National Broadband Network (NBN) continues to be rolled out.

Telstra recently revealed that it's on track to remove a total of $2.5 billion in costs by 2022. It also stated that it is on track with its EBITDA and free cash flow guidance in FY20, which is great news for shareholders and sets Telstra up for strong growth over the next few years.

Telstra's leadership position and world class network in mobile communications positions it well to fully leverage the potential opportunities of 5G technology, providing Telstra with a real opportunity to also gain new mobile broadband subscribers from dissatisfied NBN customers.

Telstra also has an attractive price-to-earnings (P/E) ratio of 11.7, which is much lower than other telcos such as Vocus Group Ltd (ASX: VOC) and TPG Telecom Ltd (ASX: TPM).

CSL Limited (ASX: CSL)

CSL has had a phenomenal run on the Australian ASX over the past 2 decades, and now sits as the second-largest company on the ASX, with a market capitalisation of $135 billion.

The company has become a global market leader in blood plasma research and disease treatment, reaching more than 60 countries.

Over the last 3 years, its earnings growth has averaged 16.5% annually, which is very impressive for a company so big. Normally as a company becomes much larger, you see an inevitable slowdown in its growth, however CSL has somehow defied this trend.

Its strong growth has been driven by high investment in research and development to create new products, and the fact that CSL's earnings base is essentially shielded from any business cycle downturn.

I feel that CSL is well positioned to continue to deliver strong earnings growth over the next decade, driven by a strong new product development pipeline and a continually growing global demand for its products.

It has a P/E ratio of 43.7, which is a bit on the high side, but still quite reasonable for such a high quality healthcare company with such a firmly entrenched market position.

Phil Harpur owns shares of CSL Ltd. and Telstra Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Telstra Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Happy woman trying to close suitcase.
Share Market News

Guess which ASX travel stock Macquarie just named as its top pick with 32% upside?

While Macquarie sees value across the sector, it named a clear favourite. 

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Share Market News

Does this broker prefer Treasury Wine or A2 Milk shares?

These consumer staples companies are comparable in size but not in upside according to this broker. 

Read more »

Broker looking at the share price.
Share Market News

5 things to watch on the ASX 200 on Wednesday

The Australian share market looks set to give back yesterday's gains.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Opinions

Why I'm buying more of these 2 ASX stocks ahead of earnings season

I've been excited about buying these investments.

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was back in the black this Tuesday.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Cromwell Property, Metcash, Pilbara Minerals, and Tyro shares are falling today

Let's see why these shares are under pressure on Tuesday.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why DroneShield, Hansen, Hub24, and Paladin Energy shares are racing higher today

These shares are having a strong session. Let's find out why.

Read more »

A man in a dark blue suit walks through an airport past floor-to-ceiling windows with a Qantas plane flying in the distance
Travel Shares

Up 16% this year, does Macquarie rate Corporate Travel Management shares a buy, hold or sell?

Does the travel stock have further to fly?

Read more »